Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 26 | 2024 | 11835 | 1.580 |
Why?
|
Myocardial Infarction | 14 | 2024 | 11891 | 0.950 |
Why?
|
Ramipril | 8 | 2023 | 97 | 0.850 |
Why?
|
Angiotensin Receptor Antagonists | 10 | 2024 | 1025 | 0.790 |
Why?
|
Stroke Volume | 21 | 2024 | 5513 | 0.630 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 7 | 2024 | 1521 | 0.570 |
Why?
|
Biphenyl Compounds | 9 | 2024 | 988 | 0.540 |
Why?
|
Tetrazoles | 10 | 2024 | 901 | 0.530 |
Why?
|
Drug Combinations | 10 | 2024 | 2024 | 0.520 |
Why?
|
Mercury Poisoning | 1 | 2015 | 32 | 0.500 |
Why?
|
Parenteral Nutrition Solutions | 1 | 2015 | 30 | 0.500 |
Why?
|
Neprilysin | 5 | 2024 | 472 | 0.480 |
Why?
|
Delivery, Obstetric | 1 | 2021 | 933 | 0.450 |
Why?
|
Mercury | 1 | 2015 | 290 | 0.410 |
Why?
|
Defibrillators, Implantable | 1 | 2021 | 1499 | 0.390 |
Why?
|
Organ Transplantation | 1 | 2021 | 1150 | 0.380 |
Why?
|
Ventricular Function, Left | 9 | 2024 | 3870 | 0.370 |
Why?
|
Pulmonary Edema | 2 | 2024 | 409 | 0.360 |
Why?
|
Parenteral Nutrition | 1 | 2015 | 651 | 0.350 |
Why?
|
Ventricular Dysfunction, Left | 5 | 2024 | 2129 | 0.350 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2021 | 2127 | 0.330 |
Why?
|
Hypotension | 3 | 2023 | 883 | 0.310 |
Why?
|
Critical Care | 1 | 2021 | 2699 | 0.310 |
Why?
|
Aortic Valve Stenosis | 1 | 2020 | 2064 | 0.280 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8058 | 0.260 |
Why?
|
Prognosis | 7 | 2023 | 29636 | 0.220 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2023 | 1705 | 0.220 |
Why?
|
Prospective Studies | 10 | 2023 | 54263 | 0.210 |
Why?
|
Hyperkalemia | 1 | 2023 | 231 | 0.190 |
Why?
|
Hospitalization | 6 | 2023 | 10761 | 0.180 |
Why?
|
Hospital Mortality | 4 | 2021 | 5420 | 0.180 |
Why?
|
Benzhydryl Compounds | 2 | 2023 | 942 | 0.170 |
Why?
|
Peptide Fragments | 2 | 2023 | 5120 | 0.170 |
Why?
|
Pulmonary Embolism | 2 | 2022 | 2544 | 0.160 |
Why?
|
Receptors, Angiotensin | 3 | 2022 | 141 | 0.150 |
Why?
|
Humans | 39 | 2024 | 760261 | 0.150 |
Why?
|
Troponin I | 1 | 2021 | 634 | 0.140 |
Why?
|
Death, Sudden, Cardiac | 1 | 2024 | 1572 | 0.130 |
Why?
|
Troponin T | 1 | 2021 | 774 | 0.130 |
Why?
|
International Classification of Diseases | 1 | 2021 | 884 | 0.130 |
Why?
|
Renin-Angiotensin System | 1 | 2020 | 739 | 0.130 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2024 | 1300 | 0.120 |
Why?
|
Echocardiography | 2 | 2024 | 4980 | 0.120 |
Why?
|
Atrial Fibrillation | 2 | 2023 | 5201 | 0.120 |
Why?
|
Inhibitor of Differentiation Protein 2 | 1 | 2014 | 30 | 0.120 |
Why?
|
Anemia | 1 | 2023 | 1511 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2014 | 256 | 0.110 |
Why?
|
Comorbidity | 3 | 2023 | 10552 | 0.100 |
Why?
|
Female | 17 | 2024 | 391011 | 0.100 |
Why?
|
Guideline Adherence | 1 | 2022 | 2283 | 0.100 |
Why?
|
Angiotensins | 2 | 2022 | 143 | 0.100 |
Why?
|
Antihypertensive Agents | 1 | 2021 | 2063 | 0.100 |
Why?
|
Cardiomyopathies | 1 | 2023 | 1945 | 0.100 |
Why?
|
Stroke | 2 | 2023 | 9945 | 0.090 |
Why?
|
Inpatients | 1 | 2022 | 2578 | 0.090 |
Why?
|
Pregnancy Outcome | 1 | 2021 | 2906 | 0.090 |
Why?
|
Oligodendroglia | 1 | 2014 | 535 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1866 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 2296 | 0.080 |
Why?
|
Calcium | 1 | 2022 | 5726 | 0.080 |
Why?
|
Glucosides | 2 | 2023 | 536 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 3223 | 0.080 |
Why?
|
Heart Diseases | 1 | 2021 | 2809 | 0.080 |
Why?
|
Aged | 10 | 2024 | 168995 | 0.070 |
Why?
|
Neural Stem Cells | 1 | 2014 | 884 | 0.070 |
Why?
|
Male | 14 | 2024 | 359413 | 0.070 |
Why?
|
Infant, Premature | 1 | 2015 | 2091 | 0.060 |
Why?
|
Risk Factors | 5 | 2024 | 74269 | 0.060 |
Why?
|
Kidney | 1 | 2020 | 7072 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2023 | 5884 | 0.060 |
Why?
|
Kansas | 1 | 2023 | 39 | 0.060 |
Why?
|
Middle Aged | 9 | 2024 | 220175 | 0.060 |
Why?
|
Registries | 1 | 2020 | 8449 | 0.060 |
Why?
|
Europe, Eastern | 1 | 2023 | 72 | 0.060 |
Why?
|
Benzylamines | 1 | 2024 | 248 | 0.050 |
Why?
|
Thrombolytic Therapy | 2 | 2022 | 2108 | 0.050 |
Why?
|
Uracil | 1 | 2024 | 207 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15827 | 0.050 |
Why?
|
Furosemide | 1 | 2022 | 170 | 0.050 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2022 | 150 | 0.050 |
Why?
|
Electrolytes | 1 | 2022 | 280 | 0.050 |
Why?
|
Pulmonary Circulation | 1 | 2024 | 743 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2024 | 64947 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8621 | 0.050 |
Why?
|
Diuretics | 1 | 2022 | 612 | 0.040 |
Why?
|
Pregnancy | 1 | 2021 | 29725 | 0.040 |
Why?
|
Self Efficacy | 1 | 2023 | 629 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2024 | 12412 | 0.040 |
Why?
|
Proportional Hazards Models | 2 | 2023 | 12532 | 0.040 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2022 | 853 | 0.040 |
Why?
|
Europe | 1 | 2023 | 3433 | 0.030 |
Why?
|
United States | 2 | 2021 | 72363 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2015 | 26168 | 0.030 |
Why?
|
Point-of-Care Systems | 1 | 2022 | 1208 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2023 | 2627 | 0.030 |
Why?
|
Infant | 1 | 2015 | 36030 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2022 | 1802 | 0.030 |
Why?
|
Up-Regulation | 1 | 2021 | 4127 | 0.020 |
Why?
|
Quality of Life | 2 | 2023 | 13300 | 0.020 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2014 | 367 | 0.020 |
Why?
|
Acute Disease | 1 | 2022 | 7268 | 0.020 |
Why?
|
Patient Care Team | 1 | 2023 | 2510 | 0.020 |
Why?
|
Hemorrhage | 1 | 2022 | 3604 | 0.020 |
Why?
|
Health Status | 1 | 2023 | 4081 | 0.020 |
Why?
|
Adult | 2 | 2021 | 219847 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8553 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 1137 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4896 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2023 | 58947 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 10340 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15273 | 0.020 |
Why?
|
Lung | 1 | 2023 | 9989 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2022 | 7809 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 5784 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2014 | 3448 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12915 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7592 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2014 | 4409 | 0.010 |
Why?
|
Tumor Microenvironment | 1 | 2014 | 3826 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 24086 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40133 | 0.010 |
Why?
|
Glioma | 1 | 2014 | 3420 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14396 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 18968 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10434 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2014 | 8498 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2014 | 11480 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15740 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 22025 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 58673 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2014 | 8984 | 0.010 |
Why?
|
Mice | 1 | 2014 | 81216 | 0.000 |
Why?
|
Animals | 1 | 2014 | 167940 | 0.000 |
Why?
|
Concepts
(133)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(32)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_